Phase II study of induction chemotherapy with gemcitabine plus 5-fluorouracil followed by gemcitabine-based concurrent chemoradiotherapy for unresectable locally advanced pancreatic cancer

Tumori

Volumn 92, Issue 6, 2006, Pages 481-486

  Kurt, Ender ^a   Kurt, Meral ^a   Kanat, Ozkan ^a   Cetintas, Sibel Kahraman ^a   Aygun, Sevilcan ^a   Palazoglu, Tulay ^a   Ozkan, Lutfi ^a   Evrensel, Turkkan ^a   Kaya, Ekrem ^a   Manavoglu, Osman ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Chemoradiotherapy; Induction chemotherapy; Pancreatic carcinoma

Indexed keywords

FLUOROURACIL; GEMCITABINE;

ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; BOLUS INJECTION; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE COURSE; DRUG DOSE REDUCTION; DUODENUM ULCER; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; MALE; MUCOSA INFLAMMATION; NAUSEA; NEUTROPENIA; PANCREAS CANCER; PHASE 2 CLINICAL TRIAL; THROMBOCYTOPENIA; TREATMENT RESPONSE;

EID: 33846599761     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160609200603     Document Type: Article

References (28)

1. Willett CG, Czito BG, Bendell JC, Ryan DP: Locally advanced pancreatic cancer. J Clin Oncol, 23: 4538-4544, 2005.
2. Yoe CJ, Yeo TP, Hruban RH, Kern SE, Iacobuzio-Donohue CA, Maitra A, Goggins M, Canto MI, Messersmith W, Abrams RA, Laheru DA, Hidalgo M, Jaffee EM: Cancer of the pancreas. In: Cancer: principles and practice of oncology, DeVita VT, Hellman S, Rosenberg SA (Eds), pp 945-986, Lippincott Williams & Wilkins, Philadelphia, 2005.
3. Pasetto LM, Jirillo A, Stefani M, Monfardini S: Is there a role for chemoradiotherapy in the treatment of pancreatic carcinoma? Anticancer Res, 23: 2805-2813, 2003.
4. Oya N: Chemoradiotherapy for pancreatic cancer: current status and perspectives. Int J Clin Oncol, 9: 451-457, 2004.
5. Moertel CG, Childs DS Jr, Reitemeier RJ, Colby MY Jr, Holbrook MA: Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet, 2: 865-867, 1969.
6. Moertel CG, Frytak S, Hahn RG, O'Connell MJ, Reitemeier RJ, Rubin J, Schutt AJ, Weiland LH, Childs DS, Holbrook MA, Lavin PT, Livstone E, Spiro H, Knowlton A, Kalser M, Barkin J, Lessner H, Mann-Kaplan R, Ramming K, Douglas HO Jr, Thomas P, Nave H, Bateman J, Lokich J, Brooks J, Chaffey J, Corson JM, Zamcheck N, Novak JW: Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group. Cancer, 48: 1705-1710, 1981.
7. Gastrointestinal Tumor Study Group: Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. J Natl Cancer Inst, 80: 751-755, 1988.
8. Burris HA 3rd, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, Cripps MC, Portenoy RK, Storniolo AM, Tarassoff P, Nelson R, Dorr FA, Stephens CD, Von Hoff DD: Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol, 15: 2403-2413, 1997.
9. Rothenberg ML, Moore MJ, Cripps MC, Andersen JS, Portenoy RK, Burris HA 3rd, Green MR, Tarassoff PG, Brown TD, Casper ES, Storniolo AM, Von Hoff DD: A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer. Ann Oncol, 7: 347-353, 1996.
10. McGinn CJ, Lawrence TS, Zalupski MM: On the development of gemcitabine-based chemoradiotherapy regimens in pancreatic cancer. Cancer, 95: 933-940, 2002.
11. Lawrence TS, Chang EY, Hahn TM, Hertel LW, Shewach DS: Radiosensitization of pancreatic cancer cells by 2′,2′-difluoro-2′- deoxycytidine. Int J Radiat Oncol Biol Phys, 34: 867-872, 1996.
12. Li CP, Chao Y, Chi KH, Chan WK, Teng HC, Lee RC, Chang FY, Lee SD, Yen SH: Concurrent chemoradiotherapy treatment of locally advanced pancreatic cancer: gemcitabine versus 5-fluorouracil, a randomized controlled study. Int J Radiat Oncol Biol Phys, 57: 98-104, 2003.
13. Okusaka T, Ito Y, Ueno H, Ikeda M, Takezako Y, Morizane C, Kagami Y, Ikeda H: Phase II study of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer. Br J Cancer, 91: 673-677, 2004.
14. World Health Organization: Handbook for reporting results of cancer treatment. WHO offset publication number 48. World Health Organization, Geneva, 1979.
15. Klaassen DJ, MacIntyre JM, Catton GE, Engstrom PF, Moertel CG: Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil - an Eastern Cooperative Oncology Group study. J Clin Oncol, 3: 373-378, 1985.
16. Epelbaum R, Rosenblatt E, Nasrallah S, Faraggi D, Gaitini D, Mizrahi S, Kuten A: Phase II study of gemcitabine combined with radiation therapy in patients with localized, unresectable pancreatic cancer. J Surg Oncol, 81: 138-143, 2002.
17. Wilkowski R, Thoma M, Weingandt H, Duhmke E, Heinemann V: Chemoradiation for ductal pancreatic carcinoma: principles of combining chemotherapy with radiation, definition of target volume and radiation dose. JOP, 6: 216-230, 2005.
18. De Lange SM, van Groeningen CJ, Meijer OW, Cuesta MA, Langendijk JA, van Riel JM, Pinedo HM, Peters GJ, Meijer S, Slotman BJ, Giaccone G: Gemcitabine-radiotherapy in patients with locally advanced pancreatic cancer. Eur J Cancer, 38: 1212-1217, 2002.
19. Shinchi H, Takao S, Noma H, Matsuo Y, Mataki Y, Mori S, Aikou T: Length and quality of survival after external-beam radiotherapy with concurrent continuous 5-fluorouracil infusion for locally unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys, 53: 146-150, 2002.
20. Aristu J, Canon R, Pardo F, Martinez-Monge R, Martin-Algarra S, Manuel Ordonez J, Villafranca E, Moreno M, Cambeiro M, Azinovic I: Surgical resection after preoperative chemoradiotherapy benefits selected patients with unresectable pancreatic cancer. Am J Clin Oncol, 26: 30-36, 2003.
21. Berlin JD, Catalano P, Thomas JP, Kugler JW, Haller DG, Benson AB 3rd: Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297. J Clin Oncol, 20: 3270-3275, 2002.
22. Kanat O, Evrensel T, Kurt E, Demiray M, Gonullu G, Arslan M, Manavoglu O: Treatment of metastatic pancreatic cancer with a combination of gemcitabine and 5-fluorouracil: a single center phase II study. Tumori, 90: 192-195, 2004.
23. Wagener DJ, Hoogenraad WJ, Rougier P, Lusinchi A, Taal BG, Veenhof CH, de Graeff A, Conroy T, Curran D, Sahmoud T, Wils J: Results of a phase II trial of epirubicin and cisplatin (EP) before and after irradiation and 5-fluorouracil in locally advanced pancreatic cancer: an EORTC GITCCG study. Eur J Cancer, 32: 1310-1313, 1996.
24. Snady H, Bruckner H, Cooperman A, Paradiso J, Kiefer L: Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma. An outcomes trial. Cancer, 89: 314-327, 2000.
25. Jessup JM, Steele G Jr, Mayer RJ, Posner M, Busse P, Cady B, Stone M, Jenkins R, Osteen R: Neoadjuvant therapy for unresectable pancreatic adenocarcinoma. Arch Surg, 128: 559-564, 1993.
26. Kim HJ, Czischke K, Brennan MF, Conlon KC: Does neoadjuvant chemoradiation downstage locally advanced pancreatic cancer? J Gastrointest Surg, 6: 763-769, 2002.
27. Crane CH, Abbruzzese JL, Evans DB, Wolff RA, Ballo MT, Delclos M, Milas L, Mason K. Charnsangavej C, Pisters PW, Lee JE, Lenzi R, Vauthey JN, Wong AB, Phan T, Nguyen Q, Janjan NA: Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer? Int J Radiat Oncol Biol Phys, 52: 1293-1302, 2002.
28. McGinn CJ, Zalupski MM, Shureiqi I, Robertson JM, Eckhauser FE, Smith DC, Brown D, Hejna G, Strawderman M, Normolle D, Lawrence TS: Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer. J Clin Oncol. 19: 4202-4208, 2001.